孟坦丁的使用在亨廷顿病中阻止了胆病的移动:一个病例报告
Kazumasa Saigoh1,2,3, Makito Hirano4, Yoshiyuki Mitsui4
1Department of Neurology, Faculty of Medicine, Kindai University, Osakasayama, Japan. saigohk@gmail.com.
Journal of medical case reports
|October 15, 2023
概括
孟坦丁有效地治疗了亨廷顿病患者的胆运动,并将疾病的进展减缓了七年. 这一案例凸显了孟坦因作为一种潜在的治疗选择,用于管理亨廷顿病的症状.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 亨廷顿病是一种自体主导性疾病,由HTT基因的CAG重复扩张引起.
- 它的特点是个性变化,精神病和非自愿的胆振运动.
- 目前,对于亨廷顿病的进展或运动症状,还没有有效的治疗方法.
研究的目的:
- 报告一例用于治疗亨廷顿病的孟坦丁治疗病例.
- 评估孟坦丁在控制运动症状和疾病进展方面的疗效.
主要方法:
- 一名75岁的患有亨廷顿病的女性患者接受了记忆剂治疗.
- 通过使用N-异烯-p-iodoamphetamine-单光子发射计算机断层扫描来评估大脑血流.
- 治疗结果在七年内进行了监测,包括步态分析.
主要成果:
- 孟坦丁的使用抑制了非自愿的胆运动.
- 观察到脑前环和脑后环圈的脑血流量下降.
- 患者在七年的治疗中经历了缓慢的症状进展.
结论:
- 在这种情况下,孟坦丁治疗有效地预防了胆病,并减缓了亨廷顿病的进展.
- 这一案例凸显了孟坦因作为亨廷顿病的潜在治疗选择.
- 研究结果为临床诊断和治疗策略提供了宝贵的见解.
相关概念视频
Parkinson's Disease: Treatment
283
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
283
Alzheimer's Disease: Treatment
211
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
211
Anticholinesterase Agents: Poisoning and Treatment
890
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
890
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
698
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
698
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
305
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
305
Mania and Antimanic Drugs: Overview
203
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
203


